Fishman S J, Feins N R, D' Amato R J, Folkman J
Department of Surgery, Children's Hospital, Boston, MA 02115, USA.
Angiogenesis. 1999;3(3):201-4. doi: 10.1023/a:1009027315912.
A 31-year-old female with severe Crohn's disease for 15 years who had been treated with corticosteroids and 6-mercaptopurine, was treated with thalidomide initially for erythema nodosum. While on thalidomide all symptoms of Crohn's disease disappeared and she was able to discontinue all other drugs. At this writing she has been on thalidomide as sole therapy for over 4 years with the exception of a 5-week hiatus, during which time her symptoms recurred, but again disappeared after resumption of thalidomide therapy. This case suggests that thalidomide may be a useful therapy for Crohn's disease and provides impetus for a clinical trial of thalidomide for Crohn's disease.
一名31岁女性,患严重克罗恩病15年,曾接受皮质类固醇和6-巯基嘌呤治疗,最初因结节性红斑接受沙利度胺治疗。在使用沙利度胺期间,克罗恩病的所有症状均消失,她能够停用所有其他药物。撰写本文时,除了有5周的中断期(在此期间症状复发,但重新开始沙利度胺治疗后症状再次消失)外,她已将沙利度胺作为唯一疗法使用了4年多。该病例表明沙利度胺可能是治疗克罗恩病的有效疗法,并为开展沙利度胺治疗克罗恩病的临床试验提供了动力。